Literature DB >> 17185377

p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix.

Xueying Wang1, Choon Hong Goh, Baojie Li.   

Abstract

p38 MAPK has been shown to regulate osteoblast differentiation. Inhibition of this kinase with inhibitors or dominant-negative mutant impedes osteoblast differentiation. Yet the molecular mechanism behind this regulation is not well understood. Here we provide evidence that the effect of p38 MAPK on osteoblast differentiation can be mediated by osterix (Osx), a transcription factor necessary and sufficient for osteoblast differentiation. Inhibition of p38 MAPK had minimal effects on differentiation of p53-/- osteoblasts, which had sustained Osx expression. Inhibition of p38 MAPK down-regulated the expression of Osx at both protein and mRNA levels, but not other transcription factors involved in osteoblast differentiation. More importantly, this inhibitory effect could be significantly relieved in osteoblasts overexpressing Osx. Further experiments support that Osx expression is mainly controlled by bone morphogenetic proteins existing in the culture medium, secreted by osteoblasts or provided by serum, and p38 MAPK plays a positive role in bone morphogenetic proteins-induced Osx expression. These findings identify a novel mechanism by which p38 MAPK regulates osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185377     DOI: 10.1210/en.2006-1000

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Apigenin promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways.

Authors:  Xue Zhang; Chenhui Zhou; Xuan Zha; Zhoumei Xu; Li Li; Yuyu Liu; Liangliang Xu; Liao Cui; Daohua Xu; Baohua Zhu
Journal:  Mol Cell Biochem       Date:  2015-05-21       Impact factor: 3.396

2.  Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.

Authors:  Sumana Posritong; Jung Min Hong; Pierre P Eleniste; Patrick W McIntyre; Jennifer L Wu; Evan R Himes; Vruti Patel; Melissa A Kacena; Angela Bruzzaniti
Journal:  Mol Cell Endocrinol       Date:  2018-02-08       Impact factor: 4.102

3.  p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.

Authors:  F Ewendt; M Föller
Journal:  J Endocrinol Invest       Date:  2019-06-14       Impact factor: 4.256

4.  p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.

Authors:  María José Ortuño; Silvia Ruiz-Gaspà; Edgardo Rodríguez-Carballo; Antonio R G Susperregui; Ramon Bartrons; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

Review 5.  Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems.

Authors:  Andrew B Yeatts; Daniel T Choquette; John P Fisher
Journal:  Biochim Biophys Acta       Date:  2012-06-15

6.  Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells.

Authors:  Karin A Payne; Laura B Meszaros; Julie A Phillippi; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2010-08-28       Impact factor: 3.845

7.  Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity.

Authors:  Caroline A Whitehouse; Sarah Waters; Katie Marchbank; Alan Horner; Neil W A McGowan; Jelena V Jovanovic; Guilherme M Xavier; Takeshi G Kashima; Martyn T Cobourne; Gareth O Richards; Paul T Sharpe; Tim M Skerry; Agamemnon E Grigoriadis; Ellen Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-29       Impact factor: 11.205

8.  Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.

Authors:  Yingli Wang; Miao Sun; Victoria L Uhlhorn; Xueyan Zhou; Inga Peter; Neus Martinez-Abadias; Cheryl A Hill; Christopher J Percival; Joan T Richtsmeier; David L Huso; Ethylin Wang Jabs
Journal:  BMC Dev Biol       Date:  2010-02-22       Impact factor: 1.978

9.  BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice.

Authors:  Maria Giovanna Sabbieti; Dimitrios Agas; Luigi Marchetti; J Douglas Coffin; Liping Xiao; Marja M Hurley
Journal:  Endocrinology       Date:  2013-05-28       Impact factor: 4.736

10.  Protein palmitoylation regulates osteoblast differentiation through BMP-induced osterix expression.

Authors:  Wai Fook Leong; Tielin Zhou; Gek Liang Lim; Baojie Li
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.